SARomics Biostructures is managed by a highly experienced team with complementary key expertise in all areas of structural biology and structure-based drug design, including protein crystallization, X-ray crystallography, NMR spectroscopy and in silico drug discovery. A selection of our recent publications may be viewed here.
SARomics Biostructures is privately owned by its founders and has no outside ownership. Please, have a look at our research services page of watch a presentation of the company at Slideshare.

Benefits of outsourcing your project to SARomics Biostructures
By outsourcing your drug discovery and structure-based drug design (SBDD) project to us, your company:

•Will avoid major investments in building up the infrastructure and expertise required at the early stages of a discovery project.

•Will receive maximum benefits thanks to our unique agreement with the Max Lab synchrotron radiation facility. The agreement provides us with quick access to a high-throuput crystallization lab and crystallography beamlines with tunable wave-length, equipped with automatic sample changer and humidity control to maximize the efficiency of data collection, save time and reduce project costs. This also allows for avoiding waiting time and transportation of crystals to remote synchrotrons.

•As a privately owned company without major investments in infrastructure we can offer highly competitive prices.

Follow us on LinkedIn